The protein pc1368 from Protochlamydia amoebophila is annotated as a conserved hypothetical protein that could be involved in the insertion of integral membrane proteins into the membrane . It belongs to the UPF0161 family and has a length of 82 amino acids . This protein is also described as a putative membrane protein insertion efficiency factor .
STRING analysis predicts several functional partners for pc1368 :
yidC: A putative 60 kDa inner-membrane protein required for the insertion, proper folding, and complex formation of integral membrane proteins into the membrane. It is involved in the integration of membrane proteins that insert both dependently and independently of the Sec translocase complex, as well as at least some lipoproteins. It also aids in the folding of multispanning membrane proteins .
pc1603: A hypothetical protein. RNase P catalyzes the removal of the 5'-leader sequence from pre-tRNA to produce the mature 5'-terminus. It can also cleave other RNA substrates such as 4.5S RNA. The protein component plays an auxiliary but essential role in vivo by binding to the 5'-leader sequence and broadening the substrate specificity of the ribozyme .
rho: A probable transcription termination factor Rho. It facilitates transcription termination by binding to the nascent RNA, activating Rho's RNA-dependent ATPase activity, and releasing the mRNA from the DNA template .
rpsD: A probable 30S ribosomal protein S4. It is one of the primary rRNA binding proteins, binding directly to 16S rRNA where it nucleates assembly of the body of the 30S subunit .
secE: A putative preprotein translocase SecE. It is an essential subunit of the Sec protein translocation channel SecYEG, clamping together the two halves of SecY and potentially contacting the channel plug during translocation .
serS: A probable seryl-tRNA synthetase. It catalyzes the attachment of serine to tRNA(Ser) and can also aminoacylate tRNA(Sec) with serine, forming the misacylated tRNA L-seryl-tRNA(Sec), which is further converted into selenocysteinyl-tRNA(Sec) .
rplB: A probable 50S ribosomal protein L2. It is one of the primary rRNA binding proteins, required for the association of the 30S and 50S subunits to form the 70S ribosome, for tRNA binding, and for peptide bond formation. It makes several contacts with the 16S rRNA in the 70S ribosome .
rplD: A putative 50S ribosomal protein L4, forming part of the polypeptide exit tunnel .
The protein pc1368 is believed to be involved in the insertion of integral membrane proteins into the membrane, sharing functional associations with YidC, which is known for its role in this process . YidC assists in the insertion and folding of membrane proteins, acting both independently and dependently of the Sec translocase complex .
Protochlamydia amoebophila is an obligate intracellular symbiont of the protozoan host Acanthamoeba sp., related to the Chlamydiaceae . Unlike many pathogenic chlamydiae, P. amoebophila establishes a long-term relationship with its host, where both organisms multiply in a synchronized manner . P. amoebophila cannot synthesize nucleotides de novo, necessitating nucleotide uptake for RNA and DNA synthesis, which is achieved through nucleotide transporters (NTTs) .
P. amoebophila has five paralogous carrier proteins belonging to the nucleotide transporter (NTT) family . These transporters play a crucial role in the bacterium's ability to exploit the host cell's metabolism .
PamNTT1: This transporter facilitates the import of ATP, stimulated by a high internal ADP/ATP ratio. Its orientation-dependent functionality ensures it does not harm P. amoebophila .
PamNTT2: Transports all four RNA nucleotides via counter exchange, showing submillimolar affinities .
PamNTT3: Catalyzes a unidirectional, proton-coupled transport of UTP .
PamNTT5: Mediates a proton-energized import of GTP and ATP .
KEGG: pcu:pc1368
STRING: 264201.pc1368
Protochlamydia amoebophila is an environmental chlamydial species that evolved as an obligate endosymbiont of amoebae approximately 700 million years ago. It belongs to the Chlamydiae phylum but, unlike pathogenic chlamydiae, has adapted to survive within protist hosts such as Acanthamoebae . Its significance for membrane protein research stems from its evolutionary position and unique adaptation strategies for intracellular survival. The bacterium modifies host-derived vesicular compartments (inclusions) through the insertion of specific membrane proteins, making it an excellent model for studying fundamental mechanisms of protein insertion into biological membranes .
While the specific pc1368 protein is not directly characterized in the available literature, Protochlamydia amoebophila UWE25 possesses several well-studied inclusion membrane proteins including IncA (pc0399), IncQ (pc0156), IncR (pc0530), and IncS (pc1111) . Unlike these confirmed inclusion membrane proteins that typically feature a bi-lobed hydrophobic domain, the putative membrane protein insertion efficiency factor (pc1368) likely serves a distinct function in facilitating the insertion of other proteins into membranes rather than being primarily a structural component itself. This functional difference distinguishes it from the 23 putative inclusion membrane proteins identified through genome-wide screening for secondary structure motifs .
For initial characterization of recombinant pc1368, a multifaceted approach similar to that used for other Protochlamydia membrane proteins is recommended:
Expression System Selection: E. coli expression systems with purification tags have been successfully used for other Protochlamydia proteins .
Protein Purification: Exclusion of hydrophobic domains when designing recombinant constructs improves solubility, as demonstrated with proteins pc0156, pc0399, pc0530, and pc1111 .
Antibody Production: Immunization protocols using purified protein fragments (excluding hydrophobic domains) in rabbits, guinea pigs, or chickens have generated specific antibodies for related proteins .
Western Blot Validation: Antibody specificity should be confirmed through Western blot analysis of E. coli expressing the recombinant protein .
Subcellular Localization: Immunofluorescence analysis and immuno-transmission electron microscopy are effective for determining the localization pattern within infected cells .
To assess the functional activity of recombinant pc1368 as a putative membrane protein insertion efficiency factor:
In Vitro Membrane Insertion Assay Protocol:
Preparation of Liposomes or Membrane Vesicles:
Prepare phospholipid vesicles mimicking bacterial membrane composition
Alternative: Isolate membrane vesicles from Acanthamoeba cells
Reporter Protein Selection:
Choose a fluorescently labeled membrane protein known to be inserted into chlamydial inclusions
Alternatively, use a membrane protein with measurable enzymatic activity
Reaction Setup:
| Component | Control Reaction | Test Reaction |
|---|---|---|
| Membrane vesicles | 100 μl | 100 μl |
| Reporter protein | 10 μg | 10 μg |
| Recombinant pc1368 | - | 5 μg |
| Buffer | To 200 μl | To 200 μl |
Measurement of Insertion Efficiency:
Quantify reporter protein incorporation into membranes via fluorescence or enzymatic activity
Compare results with/without pc1368 to determine insertion efficiency enhancement
Controls:
Negative control: heat-inactivated pc1368
Positive control: known membrane protein insertion factors if available
Establishing an expression system that preserves the native conformation of pc1368 requires attention to several key factors:
Host Selection: While E. coli is commonly used for initial expression, consider Acanthamoeba-based expression systems for membrane proteins requiring specific chaperones or post-translational modifications.
Expression Construct Design:
Include a cleavable purification tag
Consider fusion partners that enhance solubility
Evaluate the impact of removing predicted transmembrane domains
Induction Conditions:
Test multiple induction temperatures (16°C, 25°C, 37°C)
Optimize inducer concentration and induction duration
Consider auto-induction media for gradual protein expression
Membrane Fraction Isolation:
Utilize gentle lysis methods to preserve native membrane associations
Employ differential centrifugation to separate membrane fractions
Use detergent screening to identify optimal solubilization conditions
Conformational Validation:
Circular dichroism spectroscopy to verify secondary structure
Limited proteolysis to assess proper folding
Functional assays to confirm biological activity
These approaches have been successfully adapted for other membrane proteins from obligate intracellular bacteria with challenging expression profiles.
The evolutionary conservation analysis of membrane proteins in Chlamydiae reveals important distinctions between environmental and pathogenic species. While specific data on pc1368 conservation is limited, similar analyses of other membrane proteins provide insights:
Conservation Patterns Across Chlamydial Species:
| Chlamydial Group | Representative Species | Typical Conservation Pattern | Functional Implications |
|---|---|---|---|
| Environmental Chlamydiae | P. amoebophila UWE25 | Often contains larger proteins with additional domains | Adapted for amoeba interaction |
| Pathogenic Chlamydiae | C. trachomatis, C. pneumoniae | Typically shorter homologs with higher sequence conservation | Specialized for vertebrate host interaction |
When studying pc1368, researchers should examine not only sequence conservation but also domain architecture differences, as environmental chlamydiae often retain ancestral protein features that may have been lost in pathogenic lineages that underwent reductive evolution.
When faced with contradictory data regarding pc1368 localization, consider implementing this systematic troubleshooting approach:
Multiple Complementary Localization Techniques:
Immunofluorescence with antibodies targeting different epitopes
Live-cell imaging with fluorescent protein fusions
Immuno-transmission electron microscopy for ultrastructural localization
Subcellular fractionation followed by Western blotting
Temporal Analysis:
Track protein localization throughout the developmental cycle
Establish time-course experiments (24, 48, 72 hours post-infection)
Consider that localization may change during bacterial developmental stages
Co-localization Studies:
Perform dual labeling with established inclusion membrane markers
Quantify co-localization using Pearson's correlation coefficient
Test for interaction with known partners using proximity ligation assays
Host Cell Variation:
Test localization in different cell types (amoebae vs. mammalian cells)
Evaluate the impact of host cell activation status
Assess localization under different growth conditions
Technical Validation:
Verify antibody specificity using knockout controls or competing peptides
Implement super-resolution microscopy techniques for enhanced precision
Perform biological replicates across multiple independent experiments
This approach has successfully resolved localization discrepancies for other chlamydial proteins like IncA, which showed variable patterns depending on developmental stage and experimental conditions .
The putative membrane protein insertion efficiency factor pc1368 may play a crucial role in Protochlamydia's unique interaction with host cells:
Evolutionary Context:
Protochlamydia evolved as an amoebal symbiont approximately 700 million years ago, while pathogenic chlamydiae adapted to vertebrate hosts more recently . This evolutionary divergence likely shaped distinct host-interaction mechanisms.
Functional Implications:
Unlike pathogenic chlamydiae that manipulate host cells to avoid immune detection and prevent apoptosis, Protochlamydia has been shown to induce apoptosis in human immortal cell lines like HEp-2 . This suggests fundamentally different membrane-host interactions.
Structural Considerations:
P. amoebophila membrane proteins often contain additional domains not present in their pathogenic counterparts. For example, pc0399 (IncA) is notably longer than C. trachomatis IncA (840 versus 273 amino acids) and contains additional features including actin-binding motifs and repeats similar to those in Entamoeba histolytica proteins .
Potential Mechanisms:
As a membrane protein insertion efficiency factor, pc1368 may facilitate the incorporation of unique virulence factors or symbiosis-related proteins that mediate the distinct effects observed when Protochlamydia interacts with different cell types. This is supported by observations that Protochlamydia attachment, but not replication, induces apoptosis in immortal cell lines while having no effect on primary PBMCs .
Research Implications:
Understanding pc1368's role could provide insights into the molecular basis for the selective cytopathic effects observed with Protochlamydia, potentially informing novel therapeutic approaches.
When optimizing the expression and purification of recombinant pc1368, researchers should carefully control these critical parameters:
Critical Expression Parameters:
| Parameter | Optimization Range | Critical Considerations |
|---|---|---|
| Expression system | E. coli BL21(DE3), C41(DE3), C43(DE3), Acanthamoeba-based | Membrane proteins often require specialized strains |
| Induction temperature | 16-30°C | Lower temperatures reduce inclusion body formation |
| Induction time | 3-18 hours | Extended induction at lower temperatures often yields better results |
| Media composition | LB, TB, auto-induction media | Rich media can increase yield but may affect folding |
| Fusion tags | His6, MBP, SUMO, GST | N-terminal tags often perform better for membrane proteins |
Purification Considerations:
Membrane Extraction:
Test multiple detergents (DDM, LDAO, Triton X-100) at various concentrations
Consider native nanodiscs or SMALPs for maintaining membrane environment
Purification Strategy:
Implement two-step purification (affinity chromatography followed by size exclusion)
Monitor protein quality at each step via analytical SEC and/or Western blotting
Validate folding via circular dichroism or limited proteolysis
Storage Conditions:
Evaluate protein stability in different buffers and pH conditions
Test various stabilizing additives (glycerol, specific lipids, reducing agents)
Determine optimal storage temperature and freeze-thaw stability
Similar approaches have been successful for other challenging membrane proteins from obligate intracellular bacteria, including the Inc proteins of P. amoebophila .
To investigate potential interaction partners of pc1368 in Protochlamydia-infected cells, implement this comprehensive strategy:
Proximity-based Labeling Approaches:
BioID fusion with pc1368 to biotinylate nearby proteins in living cells
APEX2 fusion for proximity-dependent biotinylation with temporal control
Split-BioID to detect conditional interactions dependent on specific stimuli
Affinity Purification-Mass Spectrometry:
Generate stable cell lines expressing tagged pc1368
Perform crosslinking prior to lysis to capture transient interactions
Include appropriate controls (tag-only, unrelated membrane protein)
Implement SILAC or TMT labeling for quantitative interaction analysis
Protein-Protein Interaction Validation:
Co-immunoprecipitation of candidate interactors
Fluorescence resonance energy transfer (FRET) for in vivo interaction confirmation
Bimolecular fluorescence complementation to visualize interactions in situ
Yeast two-hybrid or bacterial two-hybrid screening for direct interactions
Functional Validation:
siRNA/CRISPR knockdown of putative partners to assess functional relevance
Competitive peptide inhibition of specific interaction domains
Site-directed mutagenesis of critical interaction residues
Data Analysis Framework:
Implement stringent statistical filtering (FDR < 1%)
Prioritize enriched proteins based on biological relevance
Conduct pathway analysis to identify functional clusters of interacting proteins
Compare interactome data with known chlamydial protein interaction networks
This approach has proven effective for mapping interaction networks of inclusion membrane proteins in related organisms and can be adapted for the study of pc1368 in Protochlamydia.
The putative membrane protein insertion efficiency factor pc1368 offers several innovative applications for studying fundamental mechanisms of membrane protein insertion:
Reconstituted In Vitro Systems:
Develop minimal reconstituted systems with purified pc1368 and synthetic membranes
Use these systems to study kinetics and thermodynamics of membrane protein insertion
Compare efficiency with other known insertion factors from diverse bacterial species
Reporter System Development:
Design reporter constructs with difficult-to-insert membrane proteins fused to easily detectable markers
Quantify insertion efficiency enhancement by pc1368 across various substrate proteins
Identify sequence and structural determinants that make proteins dependent on pc1368
Structural Biology Approaches:
Determine high-resolution structure of pc1368 alone and in complex with substrate proteins
Map functional domains through systematic mutagenesis
Identify critical residues for substrate recognition versus membrane interaction
Evolutionary Applications:
Compare pc1368 function with insertion factors from free-living bacteria and obligate pathogens
Trace the evolution of membrane protein insertion mechanisms across the bacterial domain
Identify adaptations specific to the intracellular lifestyle
Biotechnological Applications:
Exploit pc1368 to enhance expression of difficult-to-produce membrane proteins
Develop pc1368-based systems for membrane protein display technologies
Create chimeric insertion factors with enhanced or altered specificities
These approaches leverage the unique evolutionary position of Protochlamydia between free-living bacteria and obligate pathogens to gain insights into fundamental biological processes.
While Protochlamydia itself is not a human pathogen, insights from studying pc1368 could inform novel approaches for addressing pathogenic chlamydial infections:
Comparative Functional Analysis:
If pc1368 has functional homologs in pathogenic chlamydiae, understanding its mechanism could reveal vulnerabilities in essential membrane protein insertion pathways. The selective disruption of these pathways represents a potential therapeutic strategy that targets a fundamental aspect of chlamydial biology.
Differential Host Responses:
Protochlamydia induces apoptosis in immortal cell lines but not in primary cells , suggesting a selective interaction with host factors. If pc1368 contributes to this selectivity, understanding its mechanism could inform the development of interventions that selectively target infected cells while sparing healthy tissue.
Vaccine Development Considerations:
Membrane protein insertion machinery components represent potential vaccine targets due to their:
Conservation across chlamydial species
Essential function for bacterial survival
Potential accessibility to the immune system during certain stages of infection
Diagnostic Applications:
Knowledge of unique membrane protein insertion mechanisms in different chlamydial species could lead to more specific diagnostic markers that distinguish between environmental and pathogenic chlamydiae in clinical and environmental samples.
Innovative Research Tools:
Understanding pc1368 function could lead to novel research tools for studying chlamydial biology, including:
Regulated expression systems for difficult-to-manipulate obligate intracellular bacteria
New approaches for delivering biomolecules across chlamydial membranes
Improved methods for genetic manipulation of these challenging organisms